The European Medicines Agency has started a rolling review of the COVID-19 vaccine that AstraZeneca is developing with the University of Oxford.
Given that much of the evidence on the vaccine – which the EMA refers to as COVID-19 Vaccine AstraZeneca (AZD1222)...







